Merrill advises caution in '06

Merrill Lynch investors to proceed with caution in 2006 given the political risks and high valuations that currently overshadow the Israeli market.

By AVI KRAWITZ
January 12, 2006 07:08
1 minute read.
jib.awards.298.vote

jib.awards.298.vote. (photo credit: )

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Merrill Lynch investors to proceed with caution in 2006 given the political risks and high valuations that currently overshadow the Israeli market. "While market fundamentals look supportive and will not be jeopardized, we cannot ignore the key risks with the political uncertainty, elections in the Palestinian Authority and, above all, rich evaluation of the market," said Haim Israel, Research analyst at Merrill Lynch Israel in a report Wednesday. Israel said high dividend paying stocks, such as Bank Hapoalim and Bank Leumi, should be the focus for investors. He also highlighted Bezeq and Israel Chemicals as the stocks to watch in 2006, and named Comverse and Audiocodes as key performers in the technology market.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS